Bladder cancer: Always consider extravesical sites when BCG fails

首页> 外文期刊>Nature reviews. Urology >Bladder cancer: Always consider extravesical sites when BCG fails

【24h】

Bladder cancer: Always consider extravesical sites when BCG fails

机译：膀胱癌：当BCG失败时，务必考虑膀胱外部位

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Patients treated with two or more courses of BCG for high-risk non-muscle-invasive bladder cancer are at increased risk of second-site primary tumours of the upper urinary tract and prostatic urethra. A new study highlights the importance of looking for urothelial cancer in extravesical disease sites.

机译：高危非肌肉浸润性膀胱癌接受两次或两次以上卡介苗疗程的患者，上尿路和前列腺尿道发生第二部位原发肿瘤的风险增加。一项新的研究强调了在膀胱外疾病部位寻找尿路上皮癌的重要性。

著录项

来源
《Nature reviews. Urology》 |2014年第1期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Bladder cancer: Always consider extravesical sites when BCG fails [J] . Nature reviews. Urology . 2014,第1期

机译：膀胱癌：当BCG失败时，务必考虑膀胱外部位
2. Contemporary management of patients with high-risk non-muscle-invasive bladder cancer who fail intravesical BCG therapy [J] . D. R. Yates, M. Rouprêt World Journal of Urology . 2011,第4期

机译：膀胱内BCG治疗失败的高危非肌肉浸润性膀胱癌的当代管理
3. Definition and management of patients with bladder cancer who fail BCG therapy. [J] . Martin FM, Kamat AM Expert review of anticancer therapy . 2009,第6期

机译：BCG治疗失败的膀胱癌患者的定义和治疗。
4. Optimal Control on Bladder Cancer Growth Model with BCG Immunotherapy and Chemotherapy [C] . C. Dewi, Trisilowati Symposium on Biomathematics . 2015

机译：BCG免疫疗法和化疗对膀胱癌生长模型的最佳控制
5. Cystoscopy and the development of invasive bladder cancer in patients presenting with superficial urinary bladder cancer. [D] . Amos, Charles E., Jr. 2003

机译：膀胱镜检查和浅表性膀胱癌患者的浸润性膀胱癌的发展。
6. Background and Update for S1602 A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer [O] . Robert S. Svatek, Cathy Tangen, Scott Delacroix, -1

机译：S1602 III期随机试验以评估BCG初治非高度侵袭性膀胱癌的膀胱内治疗之前用皮内BCG评估BCG株差异和T细胞启动的影响的背景和更新
7. Background and Update for S1602 “A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer [O] . Robert S. Svatek, Cathy Tangen, Scott Delacroix, 2018

机译：S1602的背景和更新“A III期随机试验，以评估BCG菌株和T细胞引发与皮内BCG在BCG-Naïve高档非肌肉侵袭性膀胱癌中的膀胱内部BCG对C细胞引发的影响

Bladder cancer: Always consider extravesical sites when BCG fails

摘要

著录项

相似文献

相关主题

期刊订阅